VaramirStart free · no cardSign in
HRTX as of Nov 3 · 00:09 ET
HRTXNasdaqPharmaceutical Preparations

Heron Therapeutics, Inc. · Brief

Next report

Today

Nov 3 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±29.8%
avg realized
±19.9%
Nov 12 '24±20.4%▼−30.43%×1.50
Feb 27 '25±16.1%▲+19.88%×1.24
May 6 '25±21.3%▲+13.62%×0.64
Aug 8 '25±26.7%▼−28.26%×1.06
Q3 FY25±24.3%▼−3.39%×0.14
Q1 FY26±34.8%▲+11.11%×0.32
May 11 '26±32.7%▼−21.05%×0.64
Q2 FY26±62.0%▼−31.74%×0.51
quarterimplied−65%0+65%realized×
Q2 FY26±62.0%▼−31.74%×0.51
May '26±32.7%▼−21.05%×0.64
Q1 FY26±34.8%▲+11.11%×0.32
Q3 FY25±24.3%▼−3.39%×0.14
Aug '25±26.7%▼−28.26%×1.06
May '25±21.3%▲+13.62%×0.64
2 older reports
Feb '25±16.1%▲+19.88%×1.24
Nov '24±20.4%▼−30.43%×1.50
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2

3tracked funds holding HRTXN-PORT · Aug 31 '26
162managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

5 of 8recent reports where the move came in under the options-implied rangeEarnings history
−3.67%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

HRTX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±42.5% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.